{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:04:20Z","timestamp":1740107060571,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"crossref","award":["PIP 0154","PUE-2016"],"award-info":[{"award-number":["PIP 0154","PUE-2016"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACYT 20020170100041BA"],"award-info":[{"award-number":["UBACYT 20020170100041BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017\u20131278","PICT 2017\u20132694"],"award-info":[{"award-number":["PICT 2017\u20131278","PICT 2017\u20132694"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00109-023-02287-7","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T14:02:52Z","timestamp":1674482572000},"page":"249-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiangiogenic activity of the penicillin derivative TAP7f in melanoma"],"prefix":"10.1007","volume":"101","author":[{"given":"Elizabeth","family":"Barrionuevo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia G.","family":"Cornier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina M. L.","family":"Delpiccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto G.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor P.","family":"Roguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1103-3778","authenticated-orcid":false,"given":"Viviana C.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"2287_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27\u201331. https:\/\/doi.org\/10.1038\/nm0195-27","journal-title":"Nat Med"},{"key":"2287_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","volume":"146","author":"M Potente","year":"2011","unstructured":"Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146:873\u2013887. https:\/\/doi.org\/10.1016\/j.cell.2011.08.039","journal-title":"Cell"},{"key":"2287_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249\u2013257. https:\/\/doi.org\/10.1038\/35025220","journal-title":"Nature"},{"key":"2287_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","volume":"57","author":"J Folkman","year":"2006","unstructured":"Folkman J (2006) Angiogenesis. Annu Rev Med 57:1\u201318. https:\/\/doi.org\/10.1146\/annurev.med.57.121304.131306","journal-title":"Annu Rev Med"},{"key":"2287_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3892\/ol.2018.8733","volume":"16","author":"T Li","year":"2018","unstructured":"Li T, Kang G, Wang T, Huang H (2018) Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett 16:687\u2013702. https:\/\/doi.org\/10.3892\/ol.2018.8733","journal-title":"Oncol Lett"},{"key":"2287_CR6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","volume":"100","author":"L Lamalice","year":"2007","unstructured":"Lamalice L, Le Boeuf F, Huot J (2007) Endothelial cell migration during angiogenesis. Circ Res 100:782\u2013794. https:\/\/doi.org\/10.1161\/01.RES.0000259593.07661.1e","journal-title":"Circ Res"},{"key":"2287_CR7","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039\u20132049. https:\/\/doi.org\/10.1056\/NEJMra0706596","journal-title":"N Engl J Med"},{"key":"2287_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00109-008-0337-z","volume":"86","author":"Y Cao","year":"2008","unstructured":"Cao Y, Cao R, Hedlund E-M (2008) R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J Mol Med 86:785\u2013789. https:\/\/doi.org\/10.1007\/s00109-008-0337-z","journal-title":"J Mol Med"},{"key":"2287_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semcancer.2019.06.015","volume":"59","author":"WC Cho","year":"2019","unstructured":"Cho WC, Jour G, Aung PP (2019) Role of angiogenesis in melanoma progression: update on key angiogenic mechanisms and other associated components. Semin Cancer Biol 59:175\u2013186. https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.015","journal-title":"Semin Cancer Biol"},{"key":"2287_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1053\/j.seminoncol.2007.09.009","volume":"34","author":"GH Mahabeleshwar","year":"2007","unstructured":"Mahabeleshwar GH, Byzova TV (2007) Angiogenesis in melanoma. Semin Oncol 34:555\u2013565. https:\/\/doi.org\/10.1053\/j.seminoncol.2007.09.009","journal-title":"Semin Oncol"},{"key":"2287_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/546927","volume":"2012","author":"D Dewing","year":"2012","unstructured":"Dewing D, Emmett M, Pritchard Jones R (2012) The roles of angiogenesis in malignant melanoma: trends in basic science research over the last 100 years. ISRN Oncol 2012:1\u20137. https:\/\/doi.org\/10.5402\/2012\/546927","journal-title":"ISRN Oncol"},{"key":"2287_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/1568009043332709","volume":"4","author":"HH Luu","year":"2004","unstructured":"Luu HH, Zhang R, Haydon RC et al (2004) Wnt\/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 4:653\u2013671. https:\/\/doi.org\/10.2174\/1568009043332709","journal-title":"Curr Cancer Drug Targets"},{"key":"2287_CR13","doi-asserted-by":"publisher","unstructured":"Hodorogea A, Calinescu A, Antohe M et al (2019) Epithelial-mesenchymal transition in skin cancers: a review. Anal Cell Pathol 2019. https:\/\/doi.org\/10.1155\/2019\/3851576","DOI":"10.1155\/2019\/3851576"},{"key":"2287_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2018.00431","volume":"8","author":"V Poltavets","year":"2018","unstructured":"Poltavets V, Kochetkova M, Pitson SM, Samuel MS (2018) The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Front Oncol 8:1\u201319. https:\/\/doi.org\/10.3389\/fonc.2018.00431","journal-title":"Front Oncol"},{"key":"2287_CR15","doi-asserted-by":"publisher","unstructured":"Sottile J (2004) Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta - Rev Cancer 1654:13\u201322. https:\/\/doi.org\/10.1016\/j.bbcan.2003.07.002","DOI":"10.1016\/j.bbcan.2003.07.002"},{"key":"2287_CR16","doi-asserted-by":"publisher","unstructured":"Cornier PG, Delpiccolo CML, Mascali FC et al (2014) In vitro anticancer activity and SAR studies of triazolyl aminoacyl(peptidyl) penicillins. Medchemcomm 5. https:\/\/doi.org\/10.1039\/c3md00332a","DOI":"10.1039\/c3md00332a"},{"key":"2287_CR17","doi-asserted-by":"publisher","unstructured":"Blank V, Bellizzi Y, Zotta E et al (2018) A novel penicillin derivative induces antitumor effect in melanoma cells. Anticancer Drugs 29. https:\/\/doi.org\/10.1097\/CAD.0000000000000611","DOI":"10.1097\/CAD.0000000000000611"},{"key":"2287_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10495-021-01697-7","volume":"27","author":"Y Bellizzi","year":"2022","unstructured":"Bellizzi Y, Anselmi Relats JM, Cornier PG et al (2022) Contribution of endoplasmic reticulum stress, MAPK and PI3K\/Akt pathways to the apoptotic death induced by a penicillin derivative in melanoma cells. Apoptosis 27:34\u201348. https:\/\/doi.org\/10.1007\/s10495-021-01697-7","journal-title":"Apoptosis"},{"key":"2287_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04129-4","author":"Y Bellizzi","year":"2022","unstructured":"Bellizzi Y, Cornier PG, Delpiccolo CML et al (2022) Synergistic antitumor effect of a penicillin derivative combined with thapsigargin in melanoma cells. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-022-04129-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"2287_CR20","doi-asserted-by":"publisher","unstructured":"Barrionuevo E, Cayrol F, Cremaschi GA et al (2020) A penicillin derivative exerts an anti-metastatic activity in melanoma cells through the downregulation of integrin \u03b1v\u03b23 and Wnt\/\u03b2-catenin pathway. Front Pharmacol 11. https:\/\/doi.org\/10.3389\/fphar.2020.00127","DOI":"10.3389\/fphar.2020.00127"},{"key":"2287_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0022-1759(84)90477-0","volume":"67","author":"U Landegren","year":"1984","unstructured":"Landegren U (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67:379\u2013388. https:\/\/doi.org\/10.1016\/0022-1759(84)90477-0","journal-title":"J Immunol Methods"},{"key":"2287_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","volume":"21","author":"DR Bielenberg","year":"2015","unstructured":"Bielenberg DR, Zetter BR (2015) The contribution of angiogenesis to the process of metastasis. Cancer J 21:267\u2013273. https:\/\/doi.org\/10.1097\/PPO.0000000000000138","journal-title":"Cancer J"},{"key":"2287_CR23","doi-asserted-by":"publisher","unstructured":"Prigozhina NL, Heisel A, Wei K et al (2011) Characterization of a novel angiogenic model based on stable, fluorescently labelled endothelial cell lines amenable to scale-up for high content screening. Biol Cell 103. https:\/\/doi.org\/10.1111\/j.1768-322x.2011.tb01308.x","DOI":"10.1111\/j.1768-322x.2011.tb01308.x"},{"key":"2287_CR24","doi-asserted-by":"publisher","unstructured":"Ades EW, Candal FJ, Swerlick RA et al (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:. https:\/\/doi.org\/10.1111\/1523-1747.ep12613748","DOI":"10.1111\/1523-1747.ep12613748"},{"key":"2287_CR25","doi-asserted-by":"crossref","unstructured":"Bou\u00efs D, Hospers GAP, Meijer C et al (2001) Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4","DOI":"10.1023\/A:1012259529167"},{"key":"2287_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/jcp.1041530302","volume":"153","author":"J Bauer","year":"1992","unstructured":"Bauer J, Margolis M, Schreiner C et al (1992) In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J Cell Physiol 153:437\u2013449. https:\/\/doi.org\/10.1002\/jcp.1041530302","journal-title":"J Cell Physiol"},{"key":"2287_CR27","doi-asserted-by":"crossref","unstructured":"Bayless KJ, Johnson GA (2011) Role of the cytoskeleton in formation and maintenance of angiogenic sprouts. J Vasc Res 48","DOI":"10.1159\/000324751"},{"key":"2287_CR28","first-page":"579","volume":"10","author":"L Thoenes","year":"2008","unstructured":"Thoenes L, G\u00fcnther M (2008) Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy? Curr Opin Mol Ther 10:579\u2013590","journal-title":"Curr Opin Mol Ther"},{"key":"2287_CR29","doi-asserted-by":"publisher","unstructured":"Bhat S, Shim JS, Liu JO (2013) Tricyclic thiazoles are a new class of angiogenesis inhibitors. Bioorganic Med Chem Lett 23. https:\/\/doi.org\/10.1016\/j.bmcl.2013.02.067","DOI":"10.1016\/j.bmcl.2013.02.067"},{"key":"2287_CR30","doi-asserted-by":"publisher","unstructured":"Zhou W, Tang W, Sun Z et al (2016) Discovery and optimization of N-substituted 2-(4-pyridinyl)thiazole carboxamides against tumor growth through regulating angiogenesis signaling pathways. Sci Rep 6. https:\/\/doi.org\/10.1038\/srep33434","DOI":"10.1038\/srep33434"},{"key":"2287_CR31","doi-asserted-by":"publisher","unstructured":"Prashanth T, Thirusangu P, Vijay Avin BR et al (2014) Synthesis and evaluation of novel benzophenone-thiazole derivatives as potent VEGF-A inhibitors. Eur J Med Chem 87. https:\/\/doi.org\/10.1016\/j.ejmech.2014.09.069","DOI":"10.1016\/j.ejmech.2014.09.069"},{"key":"2287_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/cbic.201600642","volume":"18","author":"N Zabala-Uncilla","year":"2017","unstructured":"Zabala-Uncilla N, Miranda JI, Laso A et al (2017) Linear and cyclic depsipeptidomimetics with \u03b2-lactam cores: a class of new \u03b1v\u03b23 integrin receptor inhibitors. ChemBioChem 18:654\u2013665. https:\/\/doi.org\/10.1002\/cbic.201600642","journal-title":"ChemBioChem"},{"key":"2287_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3892\/or.2012.2181","volume":"29","author":"S-M Nathwani","year":"2013","unstructured":"Nathwani S-M, Hughes L, Greene LM et al (2013) Novel cis-restricted \u03b2-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro. Oncol Rep 29:585\u2013594. https:\/\/doi.org\/10.3892\/or.2012.2181","journal-title":"Oncol Rep"},{"key":"2287_CR34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/1947601911432334","volume":"2","author":"S Ziyad","year":"2011","unstructured":"Ziyad S, Iruela-Arispe ML (2011) Molecular mechanisms of tumor angiogenesis. Genes Cancer 2:1085\u20131096. https:\/\/doi.org\/10.1177\/1947601911432334","journal-title":"Genes Cancer"},{"key":"2287_CR35","doi-asserted-by":"crossref","unstructured":"Lutsenko S V., Kiselev SM, Severin SE (2003) Review: molecular mechanisms of tumor angiogenesis. Biokhimiya 68:","DOI":"10.1023\/A:1023002216413"},{"key":"2287_CR36","doi-asserted-by":"crossref","unstructured":"Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77","DOI":"10.1007\/s00018-019-03351-7"},{"key":"2287_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvq105","volume":"87","author":"DO Bates","year":"2010","unstructured":"Bates DO (2010) Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87:262\u2013271. https:\/\/doi.org\/10.1093\/cvr\/cvq105","journal-title":"Cardiovasc Res"},{"key":"2287_CR38","unstructured":"Melincovici CS, Bo\u015fca AB, \u015eu\u015fman S et al (2018) Vascular endothelial growth factor (VEGF) \u2013 key factor in normal and pathological angiogenesis. Rom J Morphol Embryol 59"},{"key":"2287_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara N, Hillan KJ, Gerber H-P, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391\u2013400. https:\/\/doi.org\/10.1038\/nrd1381","journal-title":"Nat Rev Drug Discov"},{"key":"2287_CR40","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/0008-5472.CAN-03-1489","volume":"64","author":"M Furuhashi","year":"2004","unstructured":"Furuhashi M, Sj\u00f6blom T, Abramsson A et al (2004) Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res 64:2725\u20132733. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-1489","journal-title":"Cancer Res"},{"key":"2287_CR41","first-page":"886","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sang A, Zhu M et al (2016) Tissue factor induces VEGF expression via activation of the Wnt\/\u03b2-catenin signaling pathway in ARPE-19 cells. Mol Vis 22:886\u2013897","journal-title":"Mol Vis"},{"key":"2287_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1476-4598-13-209","volume":"13","author":"JG Fern\u00e1ndez","year":"2014","unstructured":"Fern\u00e1ndez JG, Rodr\u00edguez DA, Valenzuela M et al (2014) Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K\/Akt enhanced \u03b2-catenin\/Tcf-Lef dependent transcription. Mol Cancer 13:209. https:\/\/doi.org\/10.1186\/1476-4598-13-209","journal-title":"Mol Cancer"},{"key":"2287_CR43","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3892\/ol.2014.1828","volume":"7","author":"B Qu","year":"2014","unstructured":"Qu B, Liu B-R, DU Y-J et al (2014) Wnt\/\u03b2-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett 7:1175\u20131178. https:\/\/doi.org\/10.3892\/ol.2014.1828","journal-title":"Oncol Lett"},{"key":"2287_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10456-014-9445-2","volume":"18","author":"LW Contois","year":"2015","unstructured":"Contois LW, Akalu A, Caron JM et al (2015) Inhibition of tumor-associated \u03b1v\u03b23 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo. Angiogenesis 18:31\u201346. https:\/\/doi.org\/10.1007\/s10456-014-9445-2","journal-title":"Angiogenesis"},{"key":"2287_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fendo.2019.00063","volume":"10","author":"F Cayrol","year":"2019","unstructured":"Cayrol F, Sterle HA, D\u00edaz Flaqu\u00e9 MC et al (2019) Non-genomic actions of thyroid hormones regulate the growth and angiogenesis of T cell lymphomas. Front Endocrinol (Lausanne) 10:63. https:\/\/doi.org\/10.3389\/fendo.2019.00063","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2287_CR46","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516. https:\/\/doi.org\/10.1056\/NEJMoa1103782","journal-title":"N Engl J Med"},{"key":"2287_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","volume":"380","author":"A Hauschild","year":"2012","unstructured":"Hauschild A, Grob J-J, Demidov LV et al (2012) Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet (London, England) 380:358\u2013365. https:\/\/doi.org\/10.1016\/S0140-6736(12)60868-X","journal-title":"Lancet (London, England)"},{"key":"2287_CR48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12885-017-3529-5","volume":"17","author":"MV Heppt","year":"2017","unstructured":"Heppt MV, Siepmann T, Engel J et al (2017) Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC Cancer 17:536. https:\/\/doi.org\/10.1186\/s12885-017-3529-5","journal-title":"BMC Cancer"},{"key":"2287_CR49","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/annonc\/mdx339","volume":"28","author":"PB Chapman","year":"2017","unstructured":"Chapman PB, Robert C, Larkin J et al (2017) Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study. Ann Oncol Off J Eur Soc Med Oncol 28:2581\u20132587. https:\/\/doi.org\/10.1093\/annonc\/mdx339","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2287_CR50","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/1535-7163.MCT-13-0011","volume":"12","author":"MS Carlino","year":"2013","unstructured":"Carlino MS, Gowrishankar K, Saunders CAB et al (2013) Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and\/or MEK inhibition in melanoma. Mol Cancer Ther 12:1332\u20131342. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0011","journal-title":"Mol Cancer Ther"},{"key":"2287_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ebiom.2016.04.037","volume":"8","author":"T Sinnberg","year":"2016","unstructured":"Sinnberg T, Makino E, Krueger MA et al (2016) A nexus consisting of beta-catenin and Stat3 attenuates BRAF inhibitor efficacy and mediates acquired resistance to vemurafenib. EBioMedicine 8:132\u2013149. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.037","journal-title":"EBioMedicine"},{"key":"2287_CR52","doi-asserted-by":"publisher","unstructured":"Li X, Xiang Y, Li F et al (2019) WNT\/\u03b2-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02293","DOI":"10.3389\/fimmu.2019.02293"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02287-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02287-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02287-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T20:02:35Z","timestamp":1679601755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02287-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2287"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02287-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"type":"print","value":"0946-2716"},{"type":"electronic","value":"1432-1440"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The in vivo experiments were carried out in accordance with the principles of the Basel Declaration and recommendations of the National Institute of Health (NIH) Guide for the Care and the Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee (CICUAL) of the School of Pharmacy and Biochemistry, University of Buenos Aires (14\u20131-2019\/ Res No. 217\/19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}